Making Sense of Severe Lupus: How the SLE-DAS Tool Could Improve Care Outcomes
In this episode of the Lupus Foundation of America podcast, Jaren Crump sits down with Dr. Luís Inês, rheumatologist and President of the Eu...
Radio and PodcastLive Radio & PodcastsScience & Medicine
Lupus Science and Medicine podcast
Lupus Science and Medicine is a global, peer reviewed, Open Access, online journal that provides a central point for publication of basic, clinical, translational, and epidemiological studie...
Lupus Science and Medicine podcast Podcast Guide
Listen to Lupus Science and Medicine podcast, a Science & Medicine podcast by BMJ Group. Stream 60 episodes in English, follow new audio stories, and play episodes online on Radio and Podcast.
Show Topic
Browse this show under Science & Medicine podcasts.
Episodes
20 episodes are loaded now from a catalog of 60. More episodes can be opened from this page.
Discover More
Explore Science & Medicine podcasts, Spain podcasts and English podcasts.
Episodes
20 of 60 episodesInside Lupus: The Potential of Genetic Endotypes to Personalize Lupus Care
In this episode of the Lupus Science and Medicine Podcast, host Dr. Anna Wolska speaks with Dr. Amerie Grammer about how genetic breakthroug...
Empowering Lupus Patients: A Treatment Measure Shaped by Their Voices
In this podcast, Dr. Anna Wolska sits down with Dr. Eric Morand to discuss a groundbreaking effort to improve how lupus treatment success is...
Steroid Use for the Treatment of Lupus Nephritis
Lupus nephritis, affecting nearly half of lupus patients, can cause severe kidney damage. Traditionally, high-dose glucocorticoids (~1 mg pe...
Validating Claims Algorithms for SLE: Geospatial Insights and Impacts on Health Disparities
Join Dr. Anna Wolska from the Lupus Foundation of America as she talks with Dr. Jim Oates about his recently published study in Lupus Scienc...
Rethinking Lupus Nephritis Treatment: Voclosporin vs. High-Dose Steroids
Early reduction in proteinuria is a key predictor of improved long-term kidney health in lupus nephritis (LN). In this episode, Dr. Anna Wol...
Rituximab in Childhood Lupus: Insights and Safety
Join Dr. Anna Wolska and Dr. Jordan Roberts, a pediatric rheumatologist, as they explore the use of Rituximab in treating childhood-onset sy...
Managing Pregnancy in Lupus: Contraception Use and Beyond
In this episode of the Lupus Science and Medicine podcast, Dr. Megan Clowse, a rheumatologist at Duke University, discusses her research on...
Leveraging Positive Psychosocial Factors to Manage Stress in Lupus
Join host Dr. Anna Wolska as she explores a new study in Lupus Science & Medicine on how positive psychosocial factors—such as resilience, s...
Krill Oil may represent a promising complementary therapy in SLE
Join Dr. Anna Wloska from the Lupus foundation of America and Drs. Peter Lipsky and Amerie Grammer as they discuss the effectivenss of krill...
Understanding the Critical Role of Lupus Clinical Trial Outcome Measures in Advancing Therapeutic Development
Join Dr. Anna Wolska from the Lupus Foundation of America and Dr. Laurent Arnaud, Professor of Rheumatology at the Department of Rheumatolog...
Interpreting Hydroxychloroquine Blood Levels in Lupus
Join Dr. Anna Wolska from the Lupus Foundation of America as she delves into a groundbreaking discussion with Dr. Stephen Balevic focused on...
Use of Artificial Intelligence and Machine Learning in Clinical Practice
Join Dr. Anna Wolska and Dr. May Choi as they explore the role of Artificial Intelligence (AI) and Machine Learning (ML) in guiding diagnost...
To RNase or Not to RNase: That Is the Question
Join Dr. Anna Wolska and Dr. Jim Posada as they delve into the intricacies of RNAse therapy in the management of Systemic Lupus Erythematosu...
A decision-aid facilitates patient understanding of benefits vs. risk of hydroxychloriquine use as part of routine care for lupus
Dr. Anna Wolska engages in a conversation with Dr. Shivani Garg and Dr. Christie Bartels to delve into the development and implementation of...
Dual dsDNA testing may be needed to fully understand patient disease status
Dr. Anna Wolska speaks to Dr. Michael Belmont and Devyn Zaminski to discuss the importance of dual dsDNA testing in order to full understand...
Is Anifrolumab an effective treatment for lupus nephritis?
Dr. Anna Wolska engages in a discussion with renowned experts, Dr. Catharina Lindholm and Dr. David Jayne, to explore findings from the phas...
Which one is better at controlling lupus: Belimumab or Anifrolumab?
Dr. Anna Wolska sits down with experts, Dr. Michelle Petri and Dr. Nick Ballew, analyzing the effectiveness of SLE treatments Belimumab and...
Managing Lupus Nephritis: Importance of Immunosuppression and Mitigation of Tissue Fibrosis
Dr. Anna Wolska from the Lupus Foundation of America interviews Drs. Ana Malvar and Brad Rovin. They discuss using repeat tissue biopsies to...
Testing a new measure of lupus improvement that encompasses the patients’ perspectives and doctors’ evaluations
Dr. Anna Wolska from the Lupus Foundation of America interviews Drs. Anca Askanase and Joan Merrill, the developers of the LFA-REAL tool. To...